Replacement of heme by soluble guanylate cyclase (sGC) activators abolishes heme-nitric oxide/oxygen (H-NOX) domain structural plasticity

The gasotransmitter nitric oxide (NO) is a critical endogenous regulator of homeostasis, in major part via the generation of cGMP (cyclic guanosine monophosphate) from GTP (guanosine triphosphate) by NO's main physiological receptor, the soluble guanylate cyclase (sGC). sGC is a heterodimer, co...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aikaterini I. Argyriou, Garyfallia I. Makrynitsa, Georgios Dalkas, Dimitra A. Georgopoulou, Konstantinos Salagiannis, Vassiliki Vazoura, Andreas Papapetropoulos, Stavros Topouzis, Georgios A. Spyroulias
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/cace431cf9e043178301ce8c6e55771f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cace431cf9e043178301ce8c6e55771f
record_format dspace
spelling oai:doaj.org-article:cace431cf9e043178301ce8c6e55771f2021-12-02T05:03:40ZReplacement of heme by soluble guanylate cyclase (sGC) activators abolishes heme-nitric oxide/oxygen (H-NOX) domain structural plasticity2665-928X10.1016/j.crstbi.2021.11.003https://doaj.org/article/cace431cf9e043178301ce8c6e55771f2021-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2665928X2100026Xhttps://doaj.org/toc/2665-928XThe gasotransmitter nitric oxide (NO) is a critical endogenous regulator of homeostasis, in major part via the generation of cGMP (cyclic guanosine monophosphate) from GTP (guanosine triphosphate) by NO's main physiological receptor, the soluble guanylate cyclase (sGC). sGC is a heterodimer, composed of an α1 and a β1 subunit, of which the latter contains the heme-nitric oxide/oxygen (H-NOX) domain, responsible for NO recognition, binding and signal initiation. The NO/sGC/cGMP axis is dysfunctional in a variety of diseases, including hypertension and heart failure, especially since oxidative stress results in heme oxidation, sGC unresponsiveness to NO and subsequent degradation. As a central player in this axis, sGC is the focus of intense research efforts aiming to develop therapeutic molecules that enhance its activity. A class of drugs named sGC “activators” aim to replace the oxidized heme of the H-NOX domain, thus stabilizing the enzyme and restoring its activity. Although numerous studies outline the pharmacology and binding behavior of these compounds, the static 3D models available so far do not allow a satisfactory understanding of the structural basis of sGC's activation mechanism by these drugs. Herein, application NMR describes different conformational states during the replacement of the heme by a sGC activators. We show that the two sGC activators (BAY 58-2667 and BAY 60-2770) significantly decrease the conformational plasticity of the recombinant H-NOX protein domain of Nostoc sp. cyanobacterium, rendering it a lot more rigid compared to the heme-occupied H-NOX. NMR methodology also reveals, for the first time, a surprising bi-directional competition between reduced heme and these compounds, pointing to a highly dynamic regulation of the H-NOX domain. This competitive, bi-directional mode of interaction is also confirmed by monitoring cGMP generation in A7r5 vascular smooth muscle cells by these activators. We show that, surprisingly, heme's redox state impacts differently the bioactivity of these two structurally similar compounds. In all, by NMR-based and functional approaches we contribute unique experimental insight into the dynamic interaction of sGC activators with the H-NOX domain and its dependence on the heme redox status, with the ultimate goal to permit a better design of such therapeutically important molecules.Aikaterini I. ArgyriouGaryfallia I. MakrynitsaGeorgios DalkasDimitra A. GeorgopoulouKonstantinos SalagiannisVassiliki VazouraAndreas PapapetropoulosStavros TopouzisGeorgios A. SpyrouliasElsevierarticleSoluble guanylate cyclase (sGC)HemeBAY 58-2667BAY 60-2770CinaciguatH-NOXBiology (General)QH301-705.5ENCurrent Research in Structural Biology, Vol 3, Iss , Pp 324-336 (2021)
institution DOAJ
collection DOAJ
language EN
topic Soluble guanylate cyclase (sGC)
Heme
BAY 58-2667
BAY 60-2770
Cinaciguat
H-NOX
Biology (General)
QH301-705.5
spellingShingle Soluble guanylate cyclase (sGC)
Heme
BAY 58-2667
BAY 60-2770
Cinaciguat
H-NOX
Biology (General)
QH301-705.5
Aikaterini I. Argyriou
Garyfallia I. Makrynitsa
Georgios Dalkas
Dimitra A. Georgopoulou
Konstantinos Salagiannis
Vassiliki Vazoura
Andreas Papapetropoulos
Stavros Topouzis
Georgios A. Spyroulias
Replacement of heme by soluble guanylate cyclase (sGC) activators abolishes heme-nitric oxide/oxygen (H-NOX) domain structural plasticity
description The gasotransmitter nitric oxide (NO) is a critical endogenous regulator of homeostasis, in major part via the generation of cGMP (cyclic guanosine monophosphate) from GTP (guanosine triphosphate) by NO's main physiological receptor, the soluble guanylate cyclase (sGC). sGC is a heterodimer, composed of an α1 and a β1 subunit, of which the latter contains the heme-nitric oxide/oxygen (H-NOX) domain, responsible for NO recognition, binding and signal initiation. The NO/sGC/cGMP axis is dysfunctional in a variety of diseases, including hypertension and heart failure, especially since oxidative stress results in heme oxidation, sGC unresponsiveness to NO and subsequent degradation. As a central player in this axis, sGC is the focus of intense research efforts aiming to develop therapeutic molecules that enhance its activity. A class of drugs named sGC “activators” aim to replace the oxidized heme of the H-NOX domain, thus stabilizing the enzyme and restoring its activity. Although numerous studies outline the pharmacology and binding behavior of these compounds, the static 3D models available so far do not allow a satisfactory understanding of the structural basis of sGC's activation mechanism by these drugs. Herein, application NMR describes different conformational states during the replacement of the heme by a sGC activators. We show that the two sGC activators (BAY 58-2667 and BAY 60-2770) significantly decrease the conformational plasticity of the recombinant H-NOX protein domain of Nostoc sp. cyanobacterium, rendering it a lot more rigid compared to the heme-occupied H-NOX. NMR methodology also reveals, for the first time, a surprising bi-directional competition between reduced heme and these compounds, pointing to a highly dynamic regulation of the H-NOX domain. This competitive, bi-directional mode of interaction is also confirmed by monitoring cGMP generation in A7r5 vascular smooth muscle cells by these activators. We show that, surprisingly, heme's redox state impacts differently the bioactivity of these two structurally similar compounds. In all, by NMR-based and functional approaches we contribute unique experimental insight into the dynamic interaction of sGC activators with the H-NOX domain and its dependence on the heme redox status, with the ultimate goal to permit a better design of such therapeutically important molecules.
format article
author Aikaterini I. Argyriou
Garyfallia I. Makrynitsa
Georgios Dalkas
Dimitra A. Georgopoulou
Konstantinos Salagiannis
Vassiliki Vazoura
Andreas Papapetropoulos
Stavros Topouzis
Georgios A. Spyroulias
author_facet Aikaterini I. Argyriou
Garyfallia I. Makrynitsa
Georgios Dalkas
Dimitra A. Georgopoulou
Konstantinos Salagiannis
Vassiliki Vazoura
Andreas Papapetropoulos
Stavros Topouzis
Georgios A. Spyroulias
author_sort Aikaterini I. Argyriou
title Replacement of heme by soluble guanylate cyclase (sGC) activators abolishes heme-nitric oxide/oxygen (H-NOX) domain structural plasticity
title_short Replacement of heme by soluble guanylate cyclase (sGC) activators abolishes heme-nitric oxide/oxygen (H-NOX) domain structural plasticity
title_full Replacement of heme by soluble guanylate cyclase (sGC) activators abolishes heme-nitric oxide/oxygen (H-NOX) domain structural plasticity
title_fullStr Replacement of heme by soluble guanylate cyclase (sGC) activators abolishes heme-nitric oxide/oxygen (H-NOX) domain structural plasticity
title_full_unstemmed Replacement of heme by soluble guanylate cyclase (sGC) activators abolishes heme-nitric oxide/oxygen (H-NOX) domain structural plasticity
title_sort replacement of heme by soluble guanylate cyclase (sgc) activators abolishes heme-nitric oxide/oxygen (h-nox) domain structural plasticity
publisher Elsevier
publishDate 2021
url https://doaj.org/article/cace431cf9e043178301ce8c6e55771f
work_keys_str_mv AT aikateriniiargyriou replacementofhemebysolubleguanylatecyclasesgcactivatorsabolisheshemenitricoxideoxygenhnoxdomainstructuralplasticity
AT garyfalliaimakrynitsa replacementofhemebysolubleguanylatecyclasesgcactivatorsabolisheshemenitricoxideoxygenhnoxdomainstructuralplasticity
AT georgiosdalkas replacementofhemebysolubleguanylatecyclasesgcactivatorsabolisheshemenitricoxideoxygenhnoxdomainstructuralplasticity
AT dimitraageorgopoulou replacementofhemebysolubleguanylatecyclasesgcactivatorsabolisheshemenitricoxideoxygenhnoxdomainstructuralplasticity
AT konstantinossalagiannis replacementofhemebysolubleguanylatecyclasesgcactivatorsabolisheshemenitricoxideoxygenhnoxdomainstructuralplasticity
AT vassilikivazoura replacementofhemebysolubleguanylatecyclasesgcactivatorsabolisheshemenitricoxideoxygenhnoxdomainstructuralplasticity
AT andreaspapapetropoulos replacementofhemebysolubleguanylatecyclasesgcactivatorsabolisheshemenitricoxideoxygenhnoxdomainstructuralplasticity
AT stavrostopouzis replacementofhemebysolubleguanylatecyclasesgcactivatorsabolisheshemenitricoxideoxygenhnoxdomainstructuralplasticity
AT georgiosaspyroulias replacementofhemebysolubleguanylatecyclasesgcactivatorsabolisheshemenitricoxideoxygenhnoxdomainstructuralplasticity
_version_ 1718400675784687616